Financial Ratios Hangzhou Haoyue Personal Care Co., Ltd
Equities
605009
CNE100004306
Personal Products
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.33 CNY | +0.72% |
|
+1.99% | +4.63% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 18.15 | 6.64 | 5.71 | 6.27 | 5.57 | ||||
Return on Total Capital | 22.88 | 8.34 | 7.63 | 8.3 | 7.25 | ||||
Return On Equity % | 35.14 | 12.55 | 14.08 | 14.08 | 11.89 | ||||
Return on Common Equity | 35.14 | 12.55 | 14.08 | 14.08 | 11.89 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 36.56 | 26.16 | 22.99 | 26.62 | 27.63 | ||||
SG&A Margin | 6.84 | 5.64 | 5.54 | 7.34 | 9.82 | ||||
EBITDA Margin % | 28.13 | 18.76 | 16.27 | 20.17 | 18.64 | ||||
EBITA Margin % | 26.06 | 15.91 | 13.32 | 16.2 | 14.54 | ||||
EBIT Margin % | 26 | 15.84 | 13.24 | 16.03 | 14.45 | ||||
Income From Continuing Operations Margin % | 23.23 | 14.73 | 15.09 | 15.91 | 13.23 | ||||
Net Income Margin % | 23.23 | 14.73 | 15.09 | 15.91 | 13.23 | ||||
Net Avail. For Common Margin % | 23.23 | 14.73 | 15.09 | 15.91 | 13.23 | ||||
Normalized Net Income Margin | 16.29 | 11.29 | 9.64 | 11.2 | 9.58 | ||||
Levered Free Cash Flow Margin | 4.42 | 9.95 | -0.07 | 7.63 | -10.32 | ||||
Unlevered Free Cash Flow Margin | 4.75 | 10.1 | 0.05 | 7.93 | -9.98 | ||||
Asset Turnover | |||||||||
Asset Turnover | 1.12 | 0.67 | 0.69 | 0.63 | 0.62 | ||||
Fixed Assets Turnover | 2.93 | 2.15 | 2.06 | 1.76 | 1.61 | ||||
Receivables Turnover (Average Receivables) | 25.12 | 12.43 | 9.21 | 12.22 | 15.12 | ||||
Inventory Turnover (Average Inventory) | 7.7 | 7.13 | 7.34 | 6.94 | 7.09 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 4.15 | 2.9 | 2.46 | 2.16 | 1.52 | ||||
Quick Ratio | 3.7 | 2.56 | 2.13 | 1.9 | 1.26 | ||||
Operating Cash Flow to Current Liabilities | 1.53 | 0.67 | 0.57 | 0.61 | 0.41 | ||||
Days Sales Outstanding (Average Receivables) | 14.57 | 29.36 | 39.64 | 29.88 | 24.21 | ||||
Days Outstanding Inventory (Average Inventory) | 47.51 | 51.22 | 49.73 | 52.58 | 51.64 | ||||
Average Days Payable Outstanding | 65.06 | 101.4 | 120.61 | 128.58 | 124.63 | ||||
Cash Conversion Cycle (Average Days) | -2.98 | -20.82 | -31.24 | -46.13 | -48.78 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 2.1 | 0.31 | 1.05 | 12.14 | 11.67 | ||||
Total Debt / Total Capital | 2.06 | 0.31 | 1.03 | 10.83 | 10.45 | ||||
LT Debt/Equity | - | 0.04 | 0.16 | 0.24 | 0.05 | ||||
Long-Term Debt / Total Capital | - | 0.04 | 0.16 | 0.21 | 0.05 | ||||
Total Liabilities / Total Assets | 17.68 | 24.27 | 27.63 | 30.76 | 31.96 | ||||
EBIT / Interest Expense | 48.8 | 65.41 | 66.72 | 33.54 | 26.68 | ||||
EBITDA / Interest Expense | 52.79 | 79.46 | 84.06 | 42.85 | 35 | ||||
(EBITDA - Capex) / Interest Expense | 18.71 | 38.12 | 11.71 | 21.45 | -5.86 | ||||
Total Debt / EBITDA | 0.08 | 0.02 | 0.07 | 0.69 | 0.69 | ||||
Net Debt / EBITDA | -2.5 | -4.24 | -3.95 | -3.37 | -2.01 | ||||
Total Debt / (EBITDA - Capex) | 0.23 | 0.04 | 0.48 | 1.38 | -4.14 | ||||
Net Debt / (EBITDA - Capex) | -7.04 | -8.83 | -28.31 | -6.74 | 12.01 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 32.64 | -4.98 | 13.82 | -1.62 | 6.25 | ||||
Gross Profit, 1 Yr. Growth % | 60.62 | -27.84 | 0.04 | 13.92 | 10.27 | ||||
EBITDA, 1 Yr. Growth % | 76.31 | -36.82 | -5.18 | 19.32 | -3.31 | ||||
EBITA, 1 Yr. Growth % | 80.9 | -42.19 | -9.12 | 16.51 | -4.6 | ||||
EBIT, 1 Yr. Growth % | 81.19 | -42.32 | -9.18 | 16.07 | -4.25 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 90.9 | -39.75 | 16.6 | 3.72 | -11.65 | ||||
Net Income, 1 Yr. Growth % | 90.9 | -39.75 | 16.6 | 3.72 | -11.65 | ||||
Normalized Net Income, 1 Yr. Growth % | 87.05 | -34.11 | -9.56 | 11.82 | -9.15 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 76.28 | -47.34 | 18.38 | 5.58 | -11.64 | ||||
Accounts Receivable, 1 Yr. Growth % | -7.43 | 197.13 | 5.64 | -56.6 | 83.55 | ||||
Inventory, 1 Yr. Growth % | 14.37 | 24.11 | 8.12 | -9.22 | 15.72 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 51.69 | 14.38 | 22.93 | 9.08 | 21.87 | ||||
Total Assets, 1 Yr. Growth % | 170.02 | 16.74 | 5.36 | 11.57 | 4.41 | ||||
Tangible Book Value, 1 Yr. Growth % | 372.44 | 6.45 | 0.46 | 5.83 | 2.7 | ||||
Common Equity, 1 Yr. Growth % | 336.49 | 7.4 | 0.69 | 6.76 | 2.6 | ||||
Cash From Operations, 1 Yr. Growth % | 92.51 | -26.74 | -1.81 | 32.41 | -25.52 | ||||
Capital Expenditures, 1 Yr. Growth % | 52.51 | -47.62 | 63.25 | -29.91 | 129.79 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.69T | 111.2 | -100.91 | 5.19T | -243.78 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 765.07 | 99.57 | -99.39 | 2.83T | -233.83 | ||||
Dividend Per Share, 1 Yr. Growth % | - | 49 | -25 | 126.68 | 0 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 33.69 | 12.27 | 4 | 5.82 | 2.24 | ||||
Gross Profit, 2 Yr. CAGR % | 57.62 | 4.49 | -15.03 | 6.76 | 12.08 | ||||
EBITDA, 2 Yr. CAGR % | 64.85 | 5.71 | -21.04 | 7.53 | 8.24 | ||||
EBITA, 2 Yr. CAGR % | 73.54 | 2.44 | -25.79 | 4.28 | 5.43 | ||||
EBIT, 2 Yr. CAGR % | 73.34 | 2.41 | -25.91 | 4 | 5.42 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 80.33 | 7.25 | -16.18 | 9.97 | -4.27 | ||||
Net Income, 2 Yr. CAGR % | 80.33 | 7.25 | -16.18 | 9.97 | -4.27 | ||||
Normalized Net Income, 2 Yr. CAGR % | 79.83 | 11.01 | -20 | 1.68 | 0.79 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 73.4 | -7.14 | -21.05 | 11.61 | -3.41 | ||||
Accounts Receivable, 2 Yr. CAGR % | 12.28 | 65.85 | 77.17 | -32.29 | -10.74 | ||||
Inventory, 2 Yr. CAGR % | 10.25 | 19.14 | 15.84 | -0.93 | 2.49 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 49.92 | 31.72 | 18.58 | 15.8 | 15.3 | ||||
Total Assets, 2 Yr. CAGR % | 92.07 | 77.54 | 10.9 | 8.42 | 7.93 | ||||
Tangible Book Value, 2 Yr. CAGR % | 187.04 | 124.25 | 3.41 | 3.1 | 4.25 | ||||
Common Equity, 2 Yr. CAGR % | 181.37 | 116.51 | 3.99 | 3.67 | 4.66 | ||||
Cash From Operations, 2 Yr. CAGR % | 76.72 | 18.76 | -15.19 | 14.02 | -0.69 | ||||
Capital Expenditures, 2 Yr. CAGR % | 65.58 | -10.62 | -7.53 | 6.97 | 26.91 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 25.19 | 518.81 | -86.66 | -3.88 | 772.46 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 39.46 | 317.99 | -89.36 | -2.81 | 526.59 | ||||
Dividend Per Share, 2 Yr. CAGR % | 100.04 | - | 5.71 | 30.38 | 50.56 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 50.44 | 19.31 | 12.78 | 2.09 | 5.96 | ||||
Gross Profit, 3 Yr. CAGR % | 66.89 | 19.09 | 2.99 | -6.31 | 7.91 | ||||
EBITDA, 3 Yr. CAGR % | 80.44 | 19.87 | 3.32 | -8.73 | 4.33 | ||||
EBITA, 3 Yr. CAGR % | 99.71 | 20.44 | -0.01 | -12.99 | 1.23 | ||||
EBIT, 3 Yr. CAGR % | 99.56 | 20.26 | -0.07 | -13.21 | 1.17 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 107.87 | 25.13 | 10.28 | -10.02 | 2.23 | ||||
Net Income, 3 Yr. CAGR % | 107.87 | 25.13 | 10.28 | -10.02 | 2.23 | ||||
Normalized Net Income, 3 Yr. CAGR % | 113.67 | 28.68 | 6.18 | -9.89 | -2.07 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 102.21 | 13.72 | 0.69 | -13.12 | 3.25 | ||||
Accounts Receivable, 3 Yr. CAGR % | 39.14 | 55.31 | 42.7 | 10.86 | -5.58 | ||||
Inventory, 3 Yr. CAGR % | 17.31 | 14.69 | 15.35 | 6.8 | 4.34 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 40.21 | 36.99 | 28.73 | 15.33 | 17.79 | ||||
Total Assets, 3 Yr. CAGR % | 72.1 | 62.7 | 49.2 | 11.13 | 7.07 | ||||
Tangible Book Value, 3 Yr. CAGR % | 149.48 | 106.22 | 71.59 | 4.2 | 2.97 | ||||
Common Equity, 3 Yr. CAGR % | 141.88 | 104.1 | 67.74 | 4.9 | 3.31 | ||||
Cash From Operations, 3 Yr. CAGR % | 80.49 | 31.77 | 11.46 | -1.61 | -1.07 | ||||
Capital Expenditures, 3 Yr. CAGR % | 53.11 | 12.82 | 9.25 | -15.69 | 38.02 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 37.7 | 49.67 | -31.4 | 21.94 | 9.93 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 54.11 | 57.78 | -53.71 | 20.6 | 8.13 | ||||
Dividend Per Share, 3 Yr. CAGR % | - | 81.33 | - | 36.31 | 19.35 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 39.57 | 29.79 | 13.72 | 8.44 | ||||
Gross Profit, 5 Yr. CAGR % | - | 35.38 | 25.89 | 13.99 | 6.53 | ||||
EBITDA, 5 Yr. CAGR % | - | 60.58 | 29.73 | 15.7 | 5.72 | ||||
EBITA, 5 Yr. CAGR % | - | 60.42 | 34.5 | 14.77 | 2.67 | ||||
EBIT, 5 Yr. CAGR % | - | 60.27 | 34.35 | 14.53 | 2.62 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 74.9 | 44.55 | 18.83 | 4.21 | ||||
Net Income, 5 Yr. CAGR % | - | 74.9 | 44.55 | 18.83 | 4.21 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 88.65 | 44.24 | 18.8 | 4.45 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 51.35 | 36.78 | 12.87 | -1.04 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 57.71 | 53.26 | 11.43 | 18.28 | ||||
Inventory, 5 Yr. CAGR % | - | 23.37 | 16.72 | 8.17 | 10.02 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 34.42 | 31.12 | 28.09 | 23.18 | ||||
Total Assets, 5 Yr. CAGR % | - | 49.46 | 44.36 | 38.32 | 31.07 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 130.58 | 75.4 | 56.28 | 40.58 | ||||
Common Equity, 5 Yr. CAGR % | - | 114.31 | 72.56 | 55.66 | 38.9 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 92.66 | 33.43 | 24.36 | 6.43 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 42.01 | 25.14 | 10.44 | 16 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | -45.73 | 23.55 | 116.23 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | -46.96 | 28.12 | 83.04 | ||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 58.92 | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















